Q2 2022 Holdings
Filed 2022-08-12 | 54 holdings | $17.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $11.6M | 125,087 | 64.9% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $1.9M | 883,654 | 10.5% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $1.4M | 100,000 | 7.8% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $1.1M | 125,000 | 6.3% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $1.1M | 40,000 | 6.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $589.0K | 15,000 | 3.3% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $19.6K | 359,956 | 0.1% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $17.0K | 928,256 | 0.1% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $16.4K | 937,568 | 0.1% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $15.1K | 222,173 | 0.1% |
| Travere Therapeutics Inc | NOTE 2.500% 9/1 | 761299AB2 | $10.9K | $11,000,000 | 0.1% |
| Lilly ELI & Co(LLY)Call | COM | 532457108 | $9.7K | 30,000 | 0.1% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $9.2K | 140,000 | 0.1% |
| Establishment Labs Hldgs Inc(ESTA)Put | COM | G31249108 | $8.2K | 150,000 | 0.0% |
| Nanostring Technologies Inc | NOTE 2.625% 3/0 | 63009RAD1 | $8.0K | $10,000,000 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $7.2K | 100,000 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $6.0K | 75,000 | 0.0% |
| Karuna Therapeutics IncPut | COM | 48576A100 | $5.7K | 45,000 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $5.7K | 45,000 | 0.0% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $5.6K | 85,000 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $4.7K | 215,723 | 0.0% |
| Novavax Inc(NVAX)Put | COM NEW | 670002401 | $4.6K | 90,000 | 0.0% |
| Lantheus Hldgs Inc(LNTH)Put | COM | 516544103 | $4.6K | 70,000 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $4.6K | 493,278 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $4.5K | 321,200 | 0.0% |
| Novavax Inc(NVAX)Call | COM NEW | 670002401 | $4.4K | 85,000 | 0.0% |
| Crispr Therapeutics AG(CRSP)Call | NAMEN AKT | H17182108 | $4.3K | 70,000 | 0.0% |
| Bridgebio Pharma Inc | NOTE 2.250% 2/0 | 10806XAD4 | $4.2K | $10,000,000 | 0.0% |
| Bridgebio Pharma Inc | NOTE 2.500% 3/1 | 10806XAB8 | $4.2K | $7,500,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $4.0K | 1,372,244 | 0.0% |
| Celldex Therapeutics Inc New(CLDX)Call | COM NEW | 15117B202 | $3.9K | 145,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $3.4K | 250,466 | 0.0% |
| Arya Sciences Acquisitn Corp | CLASS A ORD SHS | G31658100 | $3.4K | 352,500 | 0.0% |
| Legend Biotech Corp(LEGN)Call | SPONSORED ADS | 52490G102 | $2.8K | 50,000 | 0.0% |
| Moderna Inc(MRNA)Call | COM | 60770K107 | $2.1K | 15,000 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $2.0K | 70,000 | 0.0% |
| Vincerx Pharma Inc | COM NEW | 92731L106 | $1.8K | 1,374,098 | 0.0% |
| Fate Therapeutics Inc(FATE)Call | COM | 31189P102 | $1.7K | 67,500 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA)Call | COM | 462260100 | $1.7K | 150,000 | 0.0% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $1.4K | 75,000 | 0.0% |
| Nautilus Biotechnology Inc(NAUT) | COM | 63909J108 | $1.3K | 466,607 | 0.0% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $995 | 401,268 | 0.0% |
| Lianbio | SPONSORED ADS | 53000N108 | $972 | 450,000 | 0.0% |
| Silverback Therapeutics Inc(SPRY) | COM | 82835W108 | $721 | 170,000 | 0.0% |
| Celularity IncPut | COM CL A | 151190105 | $624 | 183,600 | 0.0% |
| Science 37 Holdings Inc | COM | 808644108 | $562 | 279,775 | 0.0% |
| Renovacor Inc | COM | 75989E106 | $405 | 199,490 | 0.0% |
| Enochian Biosciences Inc(ENOBGBP)Put | COM | 29350E104 | $386 | 200,000 | 0.0% |
| Immatics N.v | *W EXP 07/01/202 | N44445117 | $382 | 187,204 | 0.0% |
| Curis Inc(CRISEUR) | COM NEW | 231269200 | $335 | 340,349 | 0.0% |